RNA Targeting Small Molecules Therapeutics Market 2025–2029: Strategic Opportunities and Growth Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the rna targeting small molecules therapeutics market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The RNA Targeting Small Molecules Therapeutics Market Now And By 2029?

The market size for RNA targeting small molecules therapeutics has experienced substantial expansion in recent years. This sector is forecast to increase from $6.1 billion in 2024 to $7.83 billion in 2025, reflecting a compound annual growth rate (CAGR) of 28.3%. The historical surge can be attributed to drug discovery and development, the rising prevalence of RNA-related diseases, government and private funding, pharmaceutical industry interest, and RNA therapeutics success stories.

The RNA targeting small molecules therapeutics market is projected to experience substantial growth in the coming years. It is anticipated to expand to $21.95 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 29.4%. The factors contributing to this growth during the forecast period include the emergence of precision medicine and personalized therapies, an increase in RNA biomarker identification, an expanding RNA target spectrum, rising funding and investments, and its application in rare diseases. Key trends expected in the forecast period encompass advancements in screening technologies, the dominance of antisense oligonucleotides, the development of small molecule RNA binders, the use of RNA therapeutics in neurological disorders, and gene editing with CRISPR-Cas9.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12253&type=smp

Which Long-Term Drivers Are Expected To Sustain The RNA Targeting Small Molecules Therapeutics Market?

The RNA-targeting small molecule therapeutics market is projected to expand due to the rising incidence of cancer cases in the future. Cancer refers to a group of diseases that can emerge in almost any bodily organ or tissue, characterized by the uncontrolled proliferation of abnormal cells that surpass their normal limits, potentially spreading to other organs or infiltrating adjacent areas. Treatment for cancer involves RNA-targeting small molecules, specifically designed and studied to selectively target RNA molecules linked to the disease. An illustrative example comes from January 2022, where the American Cancer Society, a health organization based in the US, reported research anticipating 609,360 cancer deaths and 1.9 million new cancer cases in the US for 2022. This translates to approximately 1,670 daily fatalities. Consequently, the growing count of cancer cases is stimulating the expansion of the RNA-targeting small molecule therapeutics market.

How Is The RNA Targeting Small Molecules Therapeutics Market Classified By Different Segments?

The rna targeting small molecules therapeutics market covered in this report is segmented –

1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings

2) By Therapeutic Indication: Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications

3) By Application: Drug Discovery, Oncology Research, Disease Identification

4) By End User: Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By mRNA (Messenger Ribonucleic Acid) Translation Modulators: Small Molecule Inhibitors, Enhancers Of Translation

2) By RNA (Ribonucleic Acid) Splicing Modification: Splicing Modulators, Antisense Oligonucleotides

3) By Direct RNA (Ribonucleic Acid) Targeting: RNA-Binding Small Molecules, RNA Aptamers

4) By Other Offerings: RNA Interference (RNAi) Therapeutics, Small Molecule Activators Of RNA Stability

What Current And Upcoming Trends Are Shaping The RNA Targeting Small Molecules Therapeutics Market?

Strategic partnerships are becoming a prominent trend in the RNA-targeting small molecule therapeutics market. Leading companies in the RNA-targeting small molecule therapeutics market are engaging in collaborations to forge new relationships where multiple organizations can develop innovative products. For example, in June 2022, Otsuka Pharmaceutical Co. Ltd., a Japan-based pharmaceutical manufacturing company, collaborated with xFOREST Therapeutics Co. Ltd., a Japan-based developer of drug discovery platforms. Through this partnership, xFOREST will furnish Otsuka with its Forest technology to advance systemic small-molecule drug discovery research concentrating on RNA structures. Furthermore, in April 2024, Ipsen, a France-based biopharmaceutical company, allied with Skyhawk Therapeutics, a US-based clinical-stage biotechnology company that offers RNA-targeting small molecule therapeutics. This collaboration allowed Ipsen to focus on creating RNA-targeting small molecule drugs for rare neurological diseases and to integrate various data sets to pinpoint and develop small molecules capable of modulating RNA.

Who Are The Primary Market Leaders In The RNA Targeting Small Molecules Therapeutics Market?

Major companies operating in the RNA targeting small molecules therapeutics market include F. Hoffmann-La Roche Ltd., Bayer AG, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Janssen Pharmaceuticals, Vertex Pharmaceuticals, Servier laboratories, Genentech Inc., PTC Therapeutics Inc., Arrakis Therapeutics, Anima Biotech Inc., Skyhawk Therapeutics Inc., Remix Therapeutics, Abivax SA, 858 Therapeutics, Eloxx Pharmaceuticals Inc., STORM Therapeutics Ltd., Accent Therapeutics Inc., eFFECTOR Therapeutics Inc., EPICS Therapeutics, Expansion Therapeutics Inc., Inspirna Inc., MiNA Therapeutics Ltd., Ribometrix Inc., AC Immune SA, Redona Therapeutics

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecules-therapeutics-global-market-report

Which Regional Markets Are Emerging As Key Centers For The RNA Targeting Small Molecules Therapeutics Market?

North America was the largest region in the RNA targeting small molecules therapeutics market in 2024. The regions covered in the RNA targeting small molecules therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12253&type=smp

Browse Through More Reports Similar to the Global RNA Targeting Small Molecules Therapeutics Market 2025, By The Business Research Company

Cranes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cranes-global-market-report

Overhead Cranes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/overhead-cranes-global-market-report

Rubber Tired Gantry Crane Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rubber-tired-gantry-crane-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795